Stockchase Opinions

Robert Floyd CryoCath Technologies CYT-T HOLD Dec 17, 2004

Recently did a financing which is typical for a lot of biotech companies. Their research is very interesting. Trying to increase their marketing internationally.
$6.400

Stock price when the opinion was issued

misc industrial products
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

You might be interested:

WAIT
Have a great noninvasive product to deal with heart problems. Have a new products in the pipeline. Good potential, but may be fully valued.
HOLD
The value for stock will increase to 8 dollars. Therefore, hold the stocks.
TRADE
The market is looking for more sales from this company.
BUY
Well managed and well financed. Takeover is a possibility.
WEAK BUY
Using freezing instead of heat to treat injuries to the heart will be the big driver next year. Good technology that is being accepted. Long term should be good, but short term would be concerned about general market risk.
DON'T BUY
Just did a financing and the stock can't seem to get beyond the financing price. Unfortunately had to raise cash to get to the next level. Likes the product and the management team. Longer term, it's a good keeper, but doesn't expect a whole lot in the short term. Their US revenues have to ramp up before the market gets excited. Selling his position.
HOLD
As a medical device company its got its risks. The market they are in is not fully developed, so they need to clear the FDA hurdles, develop a market and hit their milestones. Arctic Circler(R) should be a very big piece of that. Expects to have some very good news in 05/06 on this.
COMMENT
Has some experts telling him he should be looking at this again.
TOP PICK
Treats atrial fibrillation (irregular heartbeat). This is a large coming market in cardiac area that is unsolved. The clinical trials they are doing in the US and Europe are indicating that the doctors are really adopting the product. Will probably be the leading therapy in this area. Expecting a takeout, especially if they get FDA approval.